Trial intelligence / Profile preview

Varespladib in severe sepsis

NCT00034476Phase 2Completed

Sponsor
Eli Lilly and Company
Start
Oct 2001
Countries
5
01

Overview

A Phase 2 trial of varespladib in sepsis, sponsored by Eli Lilly and Company. Started Oct 2001; status: completed.

02

Drugs

varespladib
03

Conditions

sepsis

Beyond the preview

Go deeper on NCT00034476.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00034476.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call